Clinical Trial Update: A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis [Phase 3]

View source ↗

Summary

TAK-279 is being studied in a Phase 3 trial for adults with generalized pustular psoriasis or erythrodermic psoriasis, and the study is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythrodermic Psoriasis
• Generalized Pustular Psoriasis

Drugs mentioned

• TAK-279

Snippet

Sponsor: Takeda | Conditions: Generalized Pustular Psoriasis, Erythrodermic Psoriasis | Phase 3 | Status: ACTIVE_NOT_RECRUITING